@article{3003190,
    title = "Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome",
    author = "Jalink, M. and Berentsen, S. and Castillo, J.J. and Treon, S.P. and Cruijsen, M. and Fattizzo, B. and Cassin, R. and Fotiou, D. and Kastritis, E. and De Haas, M. and Oosten, L.E.M. and Frederiksen, H. and Patriarca, A. and D'Sa, S. and Vos, J.M.I.",
    journal = "Blood advances",
    year = "2021",
    volume = "138",
    number = "20",
    pages = "2002-2005",
    publisher = "Elsevier B.V.",
    doi = "10.1182/blood.2021012039",
    keywords = "bendamustine;  bortezomib;  Bruton tyrosine kinase inhibitor;  chlorambucil;  cyclophosphamide;  dexamethasone;  fludarabine;  granulocyte colony stimulating factor;  hemoglobin;  ibrutinib;  immunoglobulin;  lactate dehydrogenase;  mycophenolate mofetil;  myeloid differentiation factor 88;  obinutuzumab;  rituximab;  steroid;  adenine;  BTK protein, human;  ibrutinib;  piperidine derivative;  protein kinase inhibitor, acrocyanosis;  aged;  autoimmune hemolytic anemia;  blood level;  chronic lymphatic leukemia;  clinical article;  clinical study;  contusion;  diarrhea;  drug efficacy;  drug substitution;  drug withdrawal;  female;  follow up;  gene mutation;  hemoglobin blood level;  hemolytic anemia;  human;  information processing;  Letter;  lymphocytic lymphoma;  male;  medical parameters;  multiple cycle treatment;  neutropenia;  plasmapheresis;  questionnaire;  rash;  retrospective study;  Waldenstroem macroglobulinemia;  autoimmune hemolytic anemia;  complication;  cyanosis;  middle aged;  very elderly, Adenine;  Agammaglobulinaemia Tyrosine Kinase;  Aged;  Aged, 80 and over;  Anemia, Hemolytic, Autoimmune;  Cyanosis;  Female;  Humans;  Male;  Middle Aged;  Piperidines;  Protein Kinase Inhibitors;  Retrospective Studies"
}